Intranasal administration of a stapled relaxin‐3 mimetic has anxiolytic‐ and antidepressant‐like activity in rats

BACKGROUND AND PURPOSE: Depression and anxiety are common causes of disability, and innovative tools and potential pharmacological targets are actively sought for prevention and treatment. Therapeutic strategies targeting the relaxin‐3 peptide or its primary endogenous receptor, RXFP3, for the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marwari, Subhi, Poulsen, Anders, Shih, Norrapat, Lakshminarayanan, Rajamani, Kini, R. Manjunatha, Johannes, Charles William, Dymock, Brian William, Dawe, Gavin Stewart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811745/
https://www.ncbi.nlm.nih.gov/pubmed/31220339
http://dx.doi.org/10.1111/bph.14774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811745/
https://www.ncbi.nlm.nih.gov/pubmed/31220339
http://dx.doi.org/10.1111/bph.14774

Ejemplares similares